Abigail A. Schweiger, BS, LMSW

Abby is a graduate of Saint Louis University with a B.S. in Psychology and a Master of Social Work. She has been a member of the Healthy Mind Lab in the Department of Psychiatry at Washington University School of Medicine since 2015.  Since then, she has worked with the team on studies investigating mHealth, novel treatments (e.g., ketamine and psilocybin) for treatment-resistant depression, understanding treatments for adults struggling with the effects of childhood trauma, and most recently, the STOP COVID study, a clinical trial of fluvoxamine for individuals with COVID-19.

Mindful MyWay Information Sheet